Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma
Am Health Drug Benefits
.
2016 Mar;9(Spec Feature):140-3.
Author
Lisa A Raedler
PMID:
27668061
PMCID:
PMC5013840
No abstract available